COMMUNIQUÉS West-GlobeNewswire

Stablecoin Development Corporation Begins Trading on NYSE American Under Ticker “SDEV”
06/04/2026
Company Announces Completion of Corporate Name Change and Provides Updated SKY Holdings and Staking Metrics EMERYVILLE, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Stablecoin Development Corporation (NYSE American: SDEV [...]
Stereotaxis Announces FDA Clearance and Launch of Synchrony System
06/04/2026
ST. LOUIS, April 06, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has received U.S. Food [...]
TOMI Environmental Solutions, Inc. Announces Surge in SteraMist Adoption Across Compounding Pharmacy Industry Amid Tightening Regulatory Standards
06/04/2026
SteraMist iHP Expansion into Compounding 503A and 503B Pharmacies FREDERICK, Md., April 06, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and [...]
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
06/04/2026
FLORHAM PARK, N.J., April 06, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) [...]
Axe Compute Names Kyle Okamoto President, Adding Deep Infrastructure Systems Expertise to Executive Team
06/04/2026
Okamoto, who helped scale Aethir's decentralized GPU network to 200+ global locations, will lead enterprise growth strategy and execution at Axe Compute PITTSBURGH, April 06, 2026 (GLOBE NEWSWIRE) -- Axe Compute (Nasdaq [...]
Verrica Pharmaceuticals to Participate in the 25th Annual Needham Virtual Healthcare Conference
06/04/2026
WEST CHESTER, Pa., April 06, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological [...]
Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors
06/04/2026
BOSTON, April 06, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., (“Avalyn” or the “Company”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare [...]
Aveanna Healthcare Announces Second Annual Aveanna Cares Month of Service
06/04/2026
ATLANTA, April 06, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare (NASDAQ: AVAH ) today announced the second year of Aveanna Cares, the company’s month-long, team-based volunteer initiative dedicated to giving back to the [...]
Extendicare Announces Timing of 2026 First Quarter Results and Conference Call
06/04/2026
MARKHAM, Ontario, April 06, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the first quarter of 2026 after market [...]
Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026
06/04/2026
MINNEAPOLIS, April 06, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2026 after the close of trading on Monday, May 4. Inspire’s [...]
Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference
06/04/2026
FOSTER CITY, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that [...]
Scienture Provides Annual Shareholder Update, Outlining Significant Progress and Strategic Priorities for the Year Ahead
06/04/2026
COMMACK, NY, April 06, 2026 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (“Scienture”) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to [...]
New LockeT Data Accepted in Leading Electrophysiology Journal
06/04/2026
FORT MILL, S.C., April 06, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”) today announced that the manuscript titled “Safety and Efficacy of LockeT Suture Retention [...]
Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
06/04/2026
SAN MATEO, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic [...]
Stipple Bio Emerges From Stealth with Oversubscribed $100 Million Series A Financing to Advance STP-100 into Early Clinical Studies and Advance a Precision Oncology Pipeline that Leverages its Pointillist Platform
06/04/2026
– Series A financing co-led by RA Capital, a16z Bio+Health and Nextech Invest, and includes participation from existing investors Emerson Collective Investments (managed by Yosemite), GV (Google Ventures), LoLa Capital [...]
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/04/2026
NEW HAVEN, Conn., April 06, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that on April 1, 2026, Invivyd granted 16 newly hired non-executive employees options to purchase an aggregate of 1,083, [...]
Kraig Biocraft Laboratories Shatters Production Record, Delivering Over 1.3 Metric Tons of Spider Silk Cocoons in a Single Month, A 5X Increase Over Previous High
06/04/2026
Record-breaking output validates aggressive scale-up strategy as Company accelerates toward 10 metric tons per month ANN ARBOR, Mich., April 06, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB [...]
ANNA Autism Care Appoints Ariana Boutain, PhD, BCBA-D as Chief Clinical Officer
06/04/2026
Mission-Driven ABA Provider Strengthens Clinical Leadership as It Scales Nationally BOSTON, April 06, 2026 (GLOBE NEWSWIRE) -- ANNA (Allied Network for Neurodevelopmental Advancement), a mission-driven provider of [...]
Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV262, a Fully CNS-Penetrant NLRP3 Inhibitor
06/04/2026
First candidate from Tenvie’s product engine to enter clinical development Phase 1 first-in-human study to evaluate single and multiple ascending doses of TNV262 in healthy volunteers and persons with obesity [...]

Pages